Jin et al. (2019) attributed the reduced activity of pathways in PBMCs to hypermethylation of their member genes, which can be a feature of particular phases during infection, e.g., RASSSF1 and cyclin-dependent kinase inhibitor 2A (CDKN2A) for chronic infection [64]. Here, CDKN2A is linked to infection.